AAV Gene Therapy Advances for Neovascular AMD and Inherited Retinal Diseases
Feb 13, 2026
AAV-based gene therapy offers sustained intraocular delivery of anti-angiogenic agents with a single treatment for neovascular AMD, with leading clinical candidates including RGX-314, ADVM-022, 4D-150, and NG101.